Switch to:
More From Other Websites
Drugmakers get mysterious invites to White House Jan 28 2015
Regeneron, Vertex execs heads to White House Jan 28 2015
Regeneron/Sanofi's PCSK9 Drug Gets FDA Priority Review - Analyst Blog Jan 27 2015
Can Celgene (CELG) Beat Earnings on Strong Product Sales? - Analyst Blog Jan 27 2015
Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst Blog Jan 27 2015
2:23 am Regeneron Pharms and Sanofi (SNY) announce Praluent... Jan 27 2015
Regeneron vaults ahead of Amgen in race to market cholesterol drug Jan 26 2015
Sanofi And Regeneron Leapfrog Amgen In New Cholesterol Drug Race Jan 26 2015
Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been... Jan 26 2015
Regeneron and Sanofi Announce Praluent™ (alirocumab) Biologics License Application has Been... Jan 26 2015
Regeneron/Sanofi cholesterol drug gets FDA priority review Jan 26 2015
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race Jan 26 2015
EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due... Jan 23 2015
EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due... Jan 23 2015
Ebola vaccine trials to begin in Liberia Jan 22 2015
US investors double down on biotech bets Jan 22 2015
Cramer's Stop Trading: Biotech hangover Jan 20 2015
Regeneron CEO: Choice, not price best for patients Jan 20 2015
New York drug developer's big money maker had nearly $1.74B in sales last year Jan 14 2015
REGENERON PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 13 2015
Regeneron and Sanofi Announce Praluent™ (alirocumab) Marketing Authorization Application has Been... Jan 12 2015
Sanofi, Regeneron submit new cholesterol drug to EMA for review Jan 12 2015
Regeneron and Sanofi Announce Praluent™ (alirocumab) Marketing Authorization Application has Been... Jan 12 2015
A volatile end to a very volatile week... Jan 09 2015
Regeneron Jumps On Favorable Cholesterol Drug Report Jan 09 2015
Regeneron to Report Fourth Quarter and Full Year 2014 Financial and Operating Results and Host... Jan 09 2015
Regeneron and Sanofi Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly... Jan 09 2015
Regeneron Announces Presentation and Panel Discussion at the 33rd Annual J.P. Morgan Healthcare... Dec 19 2014
Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations... Dec 15 2014
EYLEA® (aflibercept) Injection Accepted for Priority Review by FDA for Diabetic Retinopathy in... Dec 01 2014
New data fuels doctors' demands to rewrite U.S. heart guidelines Nov 21 2014
Sanofi touts new drugs but diabetes outlook disappoints Nov 20 2014
Sanofi and Regeneron Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in... Nov 20 2014
Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab... Nov 19 2014
Regeneron Announces EYLEA® (aflibercept) Injection Approved for the Treatment of Diabetic Macular... Nov 18 2014
Sanofi's dual-action biotech asthma drug performs well in test Nov 11 2014
Sanofi's dual-action biotech asthma drug performs well in test Nov 11 2014
Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with... Nov 11 2014
US STOCKS-Wall St slips as energy extends recent slide Nov 04 2014
Regeneron falls after paring Eylea sales outlook Nov 04 2014
US STOCKS-Futures point to lower open, energy shares in view Nov 04 2014
Regeneron Reports Third Quarter 2014 Financial and Operating Results Nov 04 2014
Regeneron Announces Upcoming 2014 Investor Conference Presentations Nov 03 2014
Regeneron and Sanofi Announce Start of Phase 3 Study of Dupilumab in Patients with Atopic Dermatitis Oct 20 2014
EYLEA® (aflibercept) Injection Demonstrates Significantly Greater Gains in Visual Acuity than Both... Oct 17 2014
Regeneron Ranked Number One Biopharmaceutical Employer by Science Magazine for Third Consecutive... Oct 16 2014
Regeneron Genetics Center Fully Operational, Announces New Collaborations and Key Appointments Oct 16 2014
Regeneron to Report Third Quarter 2014 Financial and Operating Results and Host Conference Call and... Oct 15 2014
Regeneron, Sanofi say sinusitis drug met goals Sep 30 2014
US STOCKS-Biotech shares drop, Amarin plunges 20 pct Sep 12 2014
US STOCKS-S&P 500 tops 2,000; analysts see more gains ahead Aug 25 2014
Sanofi lifts 2014 guidance after second quarter earnings beat expectations Jul 31 2014
US STOCKS-S&P 500, Nasdaq end up as Fed in no rush to raise rates Jul 30 2014
US STOCKS-S&P 500 nearly flat as investors digest Fed statement Jul 30 2014
US STOCKS-S&P 500 turns higher after Fed statement Jul 30 2014
Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials Jul 30 2014
Sanofi raises stake in Regeneron; shares jump Jul 01 2014
Valeant injects cash into bid for Botox maker Allergan May 28 2014
Wall St Week Ahead - Momentum names may see more pain Apr 04 2014
Wall St Week Ahead - Momentum names may see more pain Apr 04 2014
Sanofi and Regeneron To Present Alirocumab Clinical Data at American College of Cardiology 63rd... Mar 27 2014
Wall Street rebounds; biotech shares snap losing streak Mar 25 2014
US close: Stocks suffer heavy losses despite strong US data Mar 14 2014
U.S. FDA probes cognitive impact of new cholesterol drugs Mar 07 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK